[Clinical efficacy of sairei-to in prevention of recurrence of urethral stenosis: report of two cases].
Sairei-to has been reported to inhibit granulation and fibroblast proliferation. We administered Sairei-to (9.0 g/day) to two 77-year-old men with repeated urethral stenosis after transurethral resection of prostate (TUR-P) and examined its clinical effects. Urethral stricture did not recur in these patients for 7 to 8 months. There were no side effects in these patients. Sairei-to is suggested to be useful to prevent recurrence of urethral stricture after a transurethral procedure.
Tozawa
K
K
Department of Urology, Holy Spirit Hospital.
Akita
H
H
Yamamoto
H
H
Nakahira
Y
Y
Kawai
T
T
Kohri
K
K
D000368:Aged; D004365:Drugs, Chinese Herbal / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D011183:Postoperative Complications / Q000517:prevention & control*; D011468:Prostatectomy; D012008:Recurrence; D014525:Urethral Stricture / Q000517:prevention & control*
D004365:Drugs, Chinese Herbal; C080903:sairei-to